TANH TANTECH HOLDINGS LTD Annual reports only
Industrial Organic Chemicals · Nasdaq · SEC CIK 1588084 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 · USD | FY20242024-12-31 · USD | FY20232023-12-31 · USD | FY20222022-12-31 · USD | FY20212021-12-31 · USD |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $38.36M | $42.94M | $44.63M | $52.97M | $55.26M |
| Cost of revenue | $31.22M | $34.00M | $34.91M | $42.86M | $44.83M |
| Gross profit | $7.14M | $8.94M | $9.72M | $10.11M | $10.43M |
| R&D expense | $78,570 | $38,800 | $23,942 | $23,154 | $8.05M |
| SG&A expense | $19.26M | $4.87M | $5.82M | $3.91M | $8.83M |
| Operating income | -$12.20M | $3.98M | $3.66M | $5.93M | -$8.51M |
| Interest expense | $279,564 | $290,366 | $301,467 | $476,173 | $740,400 |
| Pretax income | -$33.50M | $624,296 | $9.27M | $7.18M | -$8.26M |
| Income tax | -$2.52M | $3.11M | $2.36M | $3.14M | $2.43M |
| Net income | -$31.02M | -$3.24M | $5.58M | $2.59M | -$8.36M |
| EBITDA | -$12.19M | $3.99M | $3.86M | $6.16M | -$8.07M |
| EPS (basic) | -13.64 | -7.66 | 80.69 | 121.21 | -48.35 |
| EPS (diluted) | -13.64 | -7.66 | 80.69 | 120.10 | -48.35 |
| Weighted avg. shares (diluted) | 2.30M | 423,174 | 69,186 | 25,154 | 172,864 |
| Banking | |||||
| Noninterest expense | — | $45,796 | $88,762 | $188,717 | $265,248 |
| Deposits | — | 500,000CNY | $500,000 | — | — |
| Balance sheet | |||||
| Cash & equivalents | $33.02M | $35.19M | $29.13M | $18.98M | $43.57M |
| Receivables | $27.80M | $32.61M | — | $40.17M | $44.96M |
| Inventory | $152,353 | $191,248 | $236,364 | $898,686 | $1.07M |
| Current assets | $73.99M | $117.80M | $115.67M | $106.76M | $105.81M |
| PP&E, net | $102,792 | $123,270 | $25,944 | $1.66M | $2.10M |
| Intangibles | $170,785 | $184,547 | $211,086 | $184,822 | $205,971 |
| Total assets | $123.97M | $142.95M | $141.69M | $134.13M | $134.53M |
| Current liabilities | $11.23M | $11.76M | $17.61M | $13.54M | $21.77M |
| Total liabilities | $13.63M | $14.68M | $18.68M | $18.20M | $21.99M |
| Shareholders' equity | $110.35M | $131.31M | $125.72M | $118.08M | $114.26M |
| Shares outstanding | — | 1.13M | 94,925 | 1.22M | 266,640 |
| Cash flow statement | |||||
| Operating cash flow | -$5.82M | $5.36M | $5.26M | $8.29M | -$8.09M |
| Capital expenditure | $0 | $80,525 | $431 | $1,571 | $220,308 |
| Free cash flow | -$5.82M | $5.28M | $5.26M | $8.29M | -$8.31M |
| Investing cash flow | -$1.08M | -$3.30M | -$2.58M | -$45.00M | $524,084 |
| Financing cash flow | $3.42M | $3.47M | $7.43M | $15.29M | $12.81M |
| Depreciation & amortization | $18,384 | $6,519 | $199,009 | $229,431 | $444,462 |
| Stock-based compensation | — | — | $0 | $0 | $1.84M |
Free plan shows the latest 5 periods; Pro shows all 13 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.